共 155 条
[1]
Aurora SK(2010)Onabotulinumtoxin A for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial Cephalalgia 30 793-803
[2]
Dodick DW(2010)OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial Cephalalgia 30 804-814
[3]
Turkel CC(2009)Tepper S %J E review of neurotherapeutics adverse effects of medications commonly used in the treatment of migraine Exp Rev Neurotherapeutics 9 1391-S28
[4]
Diener HC(2020)Neuromodulation techniques for acute and preventive migraine treatment: a systematic review and meta-analysis of randomized controlled trials J Headache Pain 21 142-12
[5]
Dodick DW(2001)Development and testing of the migraine disability assessment (MIDAS) questionnaire to assess headache-related disability Neurology 56 S20-100
[6]
Aurora SK(2013)A graphical tool for locating inconsistency in network meta-analyses BMC Med Res Methodol 13 35-145
[7]
Whyte CA(2016)Add-on deep transcranial magnetic stimulation (dTMS) for the treatment of chronic migraine: a preliminary study Neurosci Lett 623 7-2246
[8]
Moisset X(2019)Dramatic placebo effect of high frequency repetitive TMS in treatment of chronic migraine and medication overuse headache J Clin Neurosci 60 96-2801
[9]
Pereira B(2019)Effect of adjunctive intermittent theta-burst repetitive transcranial magnetic stimulation as a prophylactic treatment in migraine patients: a double-blind sham-controlled study Indian J Psychiatry 61 139-1552
[10]
Ciampi de Andrade D(2016)Efficacy of single versus three sessions of high rate repetitive transcranial magnetic stimulation in chronic migraine and tension-type headache J Neurol 263 2238-144